Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.190
+0.050 (1.59%)
At close: Jun 27, 2025, 4:00 PM
3.200
+0.010 (0.31%)
After-hours: Jun 27, 2025, 5:26 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $34.40 million as of June 27, 2025. Its market cap has decreased by -48.84% in one year.
Market Cap
34.40M
Enterprise Value
14.88M
1-Year Change
-48.84%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $34.40M, an increase of 13.43%. That is a compound annual growth rate of 2.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 34.30M | -0.31% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |